Third Arc Bio Inc., a clinical stage biotech company developing novel multifunctional antibodies for a range of oncology and immunology & inflammation (I&I) indications, today announced the first ...

We are pleased to report strong performance in 2024 as we meaningfully advanced our PBFT02 program, delivering promising data in FTD-GRN ...

Dedicated Food-Grade Production: As an FDA-registered facility, Pow.Bio offers a state-of-the-art cleanroom with pilot-scale fermentation and downstream processing, addressing production standards for ...